Impairment of B-lymphocyte differentiation induced by dual triggering of the B-cell antigen receptor and CD40 in advanced HIV-1-disease

AIDS

Volumn 12, Issue 12, 1998, Pages 1437-1449

  Conge, Anne Marie ^a,d   Tarte, Karin ^a   Reynes, Jacques ^b   Segondy, Michel ^b   Gerfaux, Jacqueline ^a   Zembala, Marek ^c   Vendrell, Jean Pierre ^a  

^a CNRS   (France)

^b MONTPELLIER UNIVERSITY HOSPITAL   (France)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^d Institute of Biology   (France)

Author keywords

Apoptosis; B lymphocytes; B cell Ag receptor and CD40 costimulation; Differentiation; HIV 1 infection

Indexed keywords

B LYMPHOCYTE ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2; LYMPHOCYTE ANTIGEN RECEPTOR; MONOCLONAL ANTIBODY; PHORBOL ESTER;

ACCESSORY CELL; ADULT; APOPTOSIS; ARTICLE; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; CELL CYCLE; CELL SEPARATION; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMOBILIZED CELL; IMMUNOGLOBULIN PRODUCTION; MALE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD40; APOPTOSIS; B-LYMPHOCYTES; CELL CYCLE; CELL DIFFERENTIATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOGLOBULIN G; IMMUNOMAGNETIC SEPARATION; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, B-CELL; VIRAL LOAD;

EID: 0032552092     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199812000-00005     Document Type: Article

References (64)

1. Lane H, Masur H, Edgar LC, Wahlen G, Rook G, Fauci AS: Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 1983, 309:453-458.
2. Schnittman SM, Lane CH, Higgins S, Folks T, Fauci AS: Direct polyclonal activation of human B lymphocytes by acquired immunodeficiency virus. Science 1986, 233:1084-1086.
3. Martinez-Maza O, Crabb E, Mitsuyasu R, Fahey J, Giorgi J: Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B-lymphocyte activation and immaturity. J Immunol 1987, 138:3720-3724.
4. Amadori A, De Rossi A, Faulkner-Valle GP, Chieco-Bianchi L: Spontaneous in vitro production of virus-specific antibody by lymphocytes from HIV-infected subjects. Clin Immunol Immunopathol 1988, 46:342-351.
5. Mizuma H, Litwin S, Zolla-Pazner S: B-cell activation in HIV infection: relationship of spontaneous immunoglobulin secretion to various immunological parameters. Clin Exp Immunol 1988, 71:410-416.
6. Vendrell JP, Segondy M, Ducos J, et al.: Analysis of the spontaneous in vitro anti-HIV-1 antibody secretion by peripheral blood mononuclear cells in HIV-1 infection. Clin Exp Immunol 1991, 83:197-202.
7. Yarchoan R, Redfield R, Broder S: Mechanisms of B-cell activation in patients with acquired immunodeficiency syndrome and related disorders. J Clin Invest 1986, 78:439-447.
8. Terpstra FG, Al BJL, Roos MTL, et al.: Longitudinal study of leukocyte functions in homosexual men seroconverted for HIV: rapid and persistent loss of B cell function after HIV infection. Eur J Immunol 1989, 19:667-673.
9. Amadori A, Zamarchi R, Veronese ML, et al.: B-cell activation during HIV-1 infection. III. Down-regulating effect of mitogens. AIDS 1991, 5:821-828.
10. Edelman AS, Zolla-Pazner S: Response of mononuclear cells from HIV-infected patients to B-cell mitogens: correlation with immunological and clinical features of disease progression. AIDS 1990, 4:859-864.
11. De Wolf F, Goudsmit J, Paul AD, et al.: Risk of AIDS related complex and AIDS in homosexual men with persistent HIV antigenaemia. BMJ 1987, 295:569-572.
12. Fenouillet E, Blanes N, Coutellier A, Demarquest J, Rozenbaum W, Gluckman JC: Monitoring of antibodies against human immunodeficiency virus type 1 p25 core protein as prognostic marker. J Infect Dis 1992, 166:611-616.
13. Strathdee SA, Frank JW, Mc Laughlin J, et al.: Quantitative measures of human immunodeficiency virus-specific antibodies predict progression to AIDS. J Infect Dis 1995, 172:1375-1379.
14. Reddy MM, Goetz RR, Gorman JM, Grieco MH, Chess L, Lederman S: Human immunodeficiency virus type-1 infection of homosexual men is accompanied by a decrease in circulating B cells. J Acquir Immune Defic Syndr 1991, 4:428-434.
15. Bass HZ, Nishanian P, Hardy WD, et al.: Immune changes in HIV-1 infection: significant correlations and differences in serum markers and lymphoïd phenotypic antigens. Clin Immunol Immunopathol 1992, 64:63-70.
16. H3 (D12 idiotope) B cells in vivo. J Acquir Immune Defic Syndr 1994, 7:641-646.
17. Chirmule N, Oyaizu N, Kalyanaraman VS, Pahwa S: Inhibition of normal B-cell function by human immunodeficiency virus envelope glycoprotein, gp120. Blood 1992, 79:1245-1259.
18. Chirmule N, Pahwa S: Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions. Microbiol Rev 1996, 60:386-406.
19. Rieckmann P, Poli G, Fox CH, Kehrl JH, Fauci A: Recombinant gp120 specifically enhances tumor necrosis factor-α production and Ig secretion in B lymphocytes from HIV-1-infected individuals but not from seronegative donors. J Immunol 1991, 147:2922-2927.
20. Boue F, Wallon C, Goujard C, Barré-Sinoussi F, Galanaud P, Delfraissy JF: HIV induces IL-6 production by human B lymphocytes. Role of IL-4. J Immunol 1992, 148:3761-3767.
21. Delfraissy JF, Wallon C, Boue F, Goujard C, Barré-Sinoussi F, Galanaud P: HIV-induced, HIV-specific in vitro antibody response by B-cells from HIV-seropositive individuals. AIDS 1992, 6:55-63.
22. H3 gene products: natural ligands for HIV gp120. Science 1993, 261:1588-1591.
23. Goodnow CC: Transgenic mice and analysis of B-cell tolerance. Annu Rev Immunol 1992, 10:409-518.
24. Fulcher DA, Lyons AB, Korn SL, et al.: The fate of self-reactive B-cells depends primarily on the degree of antigen receptor engagement and availability of T-cell help. J Exp Med 1996, 183:2313-2318.
25. Rathmell JC, Townsend SE, Xu JC, Flavell RA, Goodnow CC: Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 1996, 87:319-329.
26. Eris JM, Basten A, Brink R, Doherty K, Kehry MR, Hodgkin PD: Anergic self-reactive B cells present self antigen and respond normally to CD40-dependent T-cell signal but are defective in antigen-receptor-mediated functions. Proc Natl Acad Sci USA 1994, 91:4392-4396.
27. Parry SL, Halbold J, Holman M, Klaus GGB: Hypercross-linking surface IgM or IgG receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40. J Immunol 1994, 152:2821-2829.
28. Stamenkovic I, Clark EA, Seed B: A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J 1989, 8:1403-1410.
29. Van Kooten C, Banchereau J: CD40-CD40 ligand: a multifunctional receptor-ligand pair. Adv Immunol 1996, 61:1-77.
30. Banchereau J, Rousset F: Growing human B lymphocytes in the CD40 system. Nature 1991, 353:678-679.
31. Defrance T, Vanbervliet B, Brière F, Durand I, Rousset F, Banchereau J: Interleukin 10 and transforming growth factor β cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J Exp Med 1992, 175:671-682.
32. Rousset F, Garcia E, Defrance T, et al.: Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 1992, 89:1890-1893.
33. Brière F, Servet-Delprat C, Bridon JM, Saint-Remy JM, Banchereau J: Human interleukin-10 induces naive surface immunoglobulin D+ (slgD+) B cells to secrete IgG1 and IgG3. J Exp Med 1994, 179:757-762.
34. Fluckiger AC, Garrone P, Durand I, Galzzi JP, Banchereau J: Interleukin 10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes. J Exp Med 1993, 178:1473-1481.
35. Galibert L, Burdin N, de Saint-Vis F, et al.: CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial geminal center phenotype. J Exp Med 1996, 183:77-85.
36. Kehry MR: CD40-mediated signaling in B cells. J Immunol 1996, 156:2345-2348.
37. Valentine MA, Licciardi KA: Rescue from anti-lgM-induced programmed cell death by the B cell surface proteins CD20 and CD40. Eur J Immunol 1992, 22:3141-3148.
38. Tsubata T, Wu J, Honjo T: B-cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40. Nature 1993, 364:645-648.
39. Liu YJ, Joshua DE, Williams GT, Smith CA, Gordon J, MacLennan ICM: Mechanisms of antigen-driven selection in germinal centers. Nature 1989, 342:929-931.
40. Garrone P, Neidhardt EM, Garcia E, Galibert L, Van Kooten C, Banchereau J: Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med 1995, 182:1265-1273.
41. Bergman MC, Attrep JF, Grammer AC, Lipsky PE: Ligation of CD40 influences the function of human Ig secreting B cell hybridomas both positively and negatively. J Immunol 1996, 156:3118-3132.
42. Hess S, Engelmann H: A novel function of CD40: Induction of cell death in transformed cells. J Exp Med 1996, 183:159-167.
43. Centers for Disease Control and Prevention: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992, 41 (RR-17): 1-19.
44. Conge AM, Reynes J, Atoui N, et al.: Spontaneous in vitro anti-human immunodeficiency virus type 1 antibody secretion by peripheral blood mononuclear cells is related to disease progression in zidovudine-treated adults. J Infect Dis 1994, 170:1376-1383.
45. Suzuki U, Yamashita N, Maruyama M, Yoshikawa T, Yano S: Human lymphokine-activated killer cells suppress pokeweed mitogen-induced immunoglobulin synthesis. Clin Exp Immunol 1989, 78:406-411.
46. Van Gemen B, Kievits T, Schukkink R, et al.: Quantification of HIV-1 RNA in plasma using NASBA during HIV-1 primary infection. J Virol Methods 1993, 43:177-187.
47. Teeuwsen VJP, Logtenberg T, Siebelink KHJ, et al.: Analysis of the antigen- and mitogen-induced differentiation of B lymphocytes from asymptomatic human immunodeficiency virus-seropositive male homosexuals. J Immunol 1987, 139:2929-2935.
48. Banchereau J, Rousset F: Human B lymphocytes: phenotype, proliferation and differentiation. Adv Immunol 1992, 52:125-251.
49. Howard M, Grimaldi JC, Bazan JF et al.: Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD 38. Science 1993, 262:1056-1059.
50. Pantaleo G, Graziosi C, Fauci AS: The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 1993, 328:327-335.
51. Saag MS: Clinical spectrum of human immunodeficiency virus diseases. In AIDS: Biology, Diagnosis, Treatment and Prevention, 4th Edition. Edited by DeVita Jr VT, Hellman S, Rosenberg SA. New York: Eippincott-Raven Publishers; 1997:203-213.
52. Fahey JL, Taylor JM, Detels R, et al.: The prognostic value of cellular and serological markers in infection with human immunodeficiency virus type 1. N Engl J Med 1990, 322:166-172.
53. Verhofstede C, Reniers S, Van Wanzeele F, Plume J: Evaluation of proviral copy number and plasma RNA level as early indicators of progression in HIV-1 infection: correlation with virological and immunological markers of disease. AIDS 1994, 8:1421-1427.
54. Mellors JW, Rinaldo Jr CR, Gupta P, White RM, Todd JA, Kingsley LA: Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996, 272:1167-1170.
55. Clarck MR, Campbell KS, Kazlauskas A, et al.: The B-cell antigen receptor complex-associated of Ig-α and Ig-β with distinct cytoplasmic effectors. Science 1992, 258:123-126.
56. Lalmanach-Girard AC, Chiles TC, Parker DC, Rothstein TL: Tcell-dependent induction of NF-κB in B cells. J Exp Med 1993, 177:1215-1219.
57. Baeuerle PA, Henkel T: Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994, 12:141-179.
58. Berberich I, Shu GL, Clark EA: Cross-linking CD40 on B cells rapidly activates nuclear factor-κB. J Immunol 1994, 153:4357-4366.
59. Auphan N, Didonato JA, Rosette C, Helmberg A, Karin M: Immunosuppression by glycocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 1995, 270:286-290.
60. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS: Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 1995, 270:283-286.
61. Cayota A, Vuillier F, Siciliano J, Dighiero G: Defective protein tyrosine phosphorylation and altered levels of p59fyn and p56lck in CD4 T cells from HIV-1 infected patients. Int Immunol 1994, 6:611-621.
62. Schieven GL, Kirihara JM, Myers DE, Ledbetter JA, Uckun FM: Reactive oxygen intermediates activate NF-κB in a tyrosine kinase-dependent mechanism and in combination with vanadate activate the p56lck and p59fyn tyrosine kinases in human lymphocytes. Blood 1993, 82:1212-1220.
63. Buttke TM, Sandstrom PA: Oxidative stress as a mediator of apoptosis. Immunol Today 1994, 15:7-10.
64. Cayota A, Vuillier F, Gonzalez G, Dighiero G: In vitro antioxidant treatment recovers proliferative responses of anergic CD4+ lymphocytes from human immunodeficiency virus-infected individuals. Blood 1996, 87:4746-4753.